Tocilizumab as monotherapy or combination therapy for treating active rheumatoid arthritis: a meta-analysis of efficacy and safety reported in randomized controlled trials.

Teitsma, Xavier M; Marijnissen, Anne Karien A; Bijlsma, Johannes W J; Lafeber, Floris P J; Jacobs, Johannes W G

Teitsma, Xavier M; Marijnissen, Anne Karien A; Bijlsma, Johannes W J; Lafeber, Floris P J; Jacobs, Johannes W G.

Afiliação

Teitsma XM; Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Heidelberglaan 100, Utrecht, 3584 CX, Netherlands. x.m.teitsma@umcutrecht.nl.
Marijnissen AK; Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Heidelberglaan 100, Utrecht, 3584 CX, Netherlands.
Bijlsma JW; Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Heidelberglaan 100, Utrecht, 3584 CX, Netherlands.
Lafeber FP; Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Heidelberglaan 100, Utrecht, 3584 CX, Netherlands.
Jacobs JW; Department of Rheumatology and Clinical Immunology, University Medical Center Utrecht, Heidelberglaan 100, Utrecht, 3584 CX, Netherlands.

Arthritis Res Ther ; 18(1): 211, 2016 Sep 22.

Article em En | MEDLINE | ID: mdl-27658491

Palavras-chave

Biological; Disease-modifying anti-rheumatic drugs; Interleukin-6; Rheumatoid arthritis; Tocilizumab

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies / Systematic_reviews Idioma: En Revista: Arthritis Res Ther Assunto da revista: REUMATOLOGIA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Holanda País de publicação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google